nodes	percent_of_prediction	percent_of_DWPC	metapath
Methazolamide—CYP2C19—Prednisone—ankylosing spondylitis	0.104	0.129	CbGbCtD
Methazolamide—CYP2E1—Dexamethasone—ankylosing spondylitis	0.104	0.129	CbGbCtD
Methazolamide—SLC22A6—Methotrexate—ankylosing spondylitis	0.0949	0.117	CbGbCtD
Methazolamide—CYP3A4—Methylprednisolone—ankylosing spondylitis	0.0833	0.103	CbGbCtD
Methazolamide—CYP2C19—Dexamethasone—ankylosing spondylitis	0.0652	0.0807	CbGbCtD
Methazolamide—CYP3A4—Triamcinolone—ankylosing spondylitis	0.0631	0.0781	CbGbCtD
Methazolamide—CYP2C9—Dexamethasone—ankylosing spondylitis	0.0542	0.0671	CbGbCtD
Methazolamide—CYP3A4—Betamethasone—ankylosing spondylitis	0.0542	0.067	CbGbCtD
Methazolamide—CYP3A4—Prednisolone—ankylosing spondylitis	0.0535	0.0661	CbGbCtD
Methazolamide—CYP3A4—Prednisone—ankylosing spondylitis	0.0505	0.0625	CbGbCtD
Methazolamide—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0496	0.0613	CbGbCtD
Methazolamide—CYP3A4—Dexamethasone—ankylosing spondylitis	0.0315	0.039	CbGbCtD
Methazolamide—Hepatic insufficiency—Methotrexate—ankylosing spondylitis	0.0116	0.0607	CcSEcCtD
Methazolamide—Metabolic acidosis—Methylprednisolone—ankylosing spondylitis	0.00688	0.0359	CcSEcCtD
Methazolamide—Electrolyte imbalance—Methylprednisolone—ankylosing spondylitis	0.00651	0.0339	CcSEcCtD
Methazolamide—Electrolyte imbalance—Betamethasone—ankylosing spondylitis	0.00592	0.0309	CcSEcCtD
Methazolamide—Electrolyte imbalance—Dexamethasone—ankylosing spondylitis	0.00592	0.0309	CcSEcCtD
Methazolamide—Appetite absent—Methotrexate—ankylosing spondylitis	0.00362	0.0189	CcSEcCtD
Methazolamide—Tingling sensation—Methylprednisolone—ankylosing spondylitis	0.00338	0.0176	CcSEcCtD
Methazolamide—Glycosuria—Triamcinolone—ankylosing spondylitis	0.00336	0.0175	CcSEcCtD
Methazolamide—Glycosuria—Methylprednisolone—ankylosing spondylitis	0.00336	0.0175	CcSEcCtD
Methazolamide—Tingling sensation—Betamethasone—ankylosing spondylitis	0.00308	0.016	CcSEcCtD
Methazolamide—Tingling sensation—Dexamethasone—ankylosing spondylitis	0.00308	0.016	CcSEcCtD
Methazolamide—Glycosuria—Dexamethasone—ankylosing spondylitis	0.00305	0.0159	CcSEcCtD
Methazolamide—Glycosuria—Betamethasone—ankylosing spondylitis	0.00305	0.0159	CcSEcCtD
Methazolamide—Bone marrow depression—Methotrexate—ankylosing spondylitis	0.00267	0.0139	CcSEcCtD
Methazolamide—Glycosuria—Prednisone—ankylosing spondylitis	0.00266	0.0139	CcSEcCtD
Methazolamide—Melaena—Methotrexate—ankylosing spondylitis	0.00176	0.00917	CcSEcCtD
Methazolamide—Aplastic anaemia—Methotrexate—ankylosing spondylitis	0.00169	0.00881	CcSEcCtD
Methazolamide—Urine output increased—Methotrexate—ankylosing spondylitis	0.00163	0.00848	CcSEcCtD
Methazolamide—Photosensitivity—Methotrexate—ankylosing spondylitis	0.00149	0.00776	CcSEcCtD
Methazolamide—Polyuria—Methotrexate—ankylosing spondylitis	0.00149	0.00776	CcSEcCtD
Methazolamide—Hepatic failure—Methotrexate—ankylosing spondylitis	0.00145	0.00758	CcSEcCtD
Methazolamide—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.0012	0.00627	CcSEcCtD
Methazolamide—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.00118	0.00613	CcSEcCtD
Methazolamide—Malaise—Prednisolone—ankylosing spondylitis	0.00117	0.00609	CcSEcCtD
Methazolamide—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00117	0.00608	CcSEcCtD
Methazolamide—Vertigo—Prednisolone—ankylosing spondylitis	0.00116	0.00607	CcSEcCtD
Methazolamide—Convulsion—Prednisolone—ankylosing spondylitis	0.00112	0.00585	CcSEcCtD
Methazolamide—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.00111	0.00576	CcSEcCtD
Methazolamide—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.0011	0.00575	CcSEcCtD
Methazolamide—Discomfort—Prednisolone—ankylosing spondylitis	0.00109	0.00568	CcSEcCtD
Methazolamide—Malaise—Triamcinolone—ankylosing spondylitis	0.00107	0.0056	CcSEcCtD
Methazolamide—Pancytopenia—Methotrexate—ankylosing spondylitis	0.00107	0.00559	CcSEcCtD
Methazolamide—Malaise—Methylprednisolone—ankylosing spondylitis	0.00107	0.00559	CcSEcCtD
Methazolamide—Vertigo—Triamcinolone—ankylosing spondylitis	0.00107	0.00558	CcSEcCtD
Methazolamide—Vertigo—Methylprednisolone—ankylosing spondylitis	0.00107	0.00557	CcSEcCtD
Methazolamide—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.00106	0.00551	CcSEcCtD
Methazolamide—Convulsion—Triamcinolone—ankylosing spondylitis	0.00103	0.00538	CcSEcCtD
Methazolamide—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.00103	0.00537	CcSEcCtD
Methazolamide—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00103	0.00537	CcSEcCtD
Methazolamide—Drowsiness—Methotrexate—ankylosing spondylitis	0.00101	0.00525	CcSEcCtD
Methazolamide—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.001	0.00523	CcSEcCtD
Methazolamide—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.001	0.00523	CcSEcCtD
Methazolamide—Discomfort—Triamcinolone—ankylosing spondylitis	0.001	0.00522	CcSEcCtD
Methazolamide—Discomfort—Methylprednisolone—ankylosing spondylitis	0.001	0.00521	CcSEcCtD
Methazolamide—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.000998	0.0052	CcSEcCtD
Methazolamide—Confusional state—Methylprednisolone—ankylosing spondylitis	0.000978	0.0051	CcSEcCtD
Methazolamide—Malaise—Dexamethasone—ankylosing spondylitis	0.000975	0.00508	CcSEcCtD
Methazolamide—Malaise—Betamethasone—ankylosing spondylitis	0.000975	0.00508	CcSEcCtD
Methazolamide—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000972	0.00507	CcSEcCtD
Methazolamide—Vertigo—Betamethasone—ankylosing spondylitis	0.000971	0.00506	CcSEcCtD
Methazolamide—Vertigo—Dexamethasone—ankylosing spondylitis	0.000971	0.00506	CcSEcCtD
Methazolamide—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.00097	0.00506	CcSEcCtD
Methazolamide—Haematuria—Methotrexate—ankylosing spondylitis	0.00096	0.005	CcSEcCtD
Methazolamide—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000949	0.00495	CcSEcCtD
Methazolamide—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00094	0.0049	CcSEcCtD
Methazolamide—Convulsion—Betamethasone—ankylosing spondylitis	0.000937	0.00488	CcSEcCtD
Methazolamide—Convulsion—Dexamethasone—ankylosing spondylitis	0.000937	0.00488	CcSEcCtD
Methazolamide—Discomfort—Betamethasone—ankylosing spondylitis	0.000909	0.00474	CcSEcCtD
Methazolamide—Discomfort—Dexamethasone—ankylosing spondylitis	0.000909	0.00474	CcSEcCtD
Methazolamide—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000882	0.0046	CcSEcCtD
Methazolamide—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000882	0.0046	CcSEcCtD
Methazolamide—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000874	0.00455	CcSEcCtD
Methazolamide—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000873	0.00455	CcSEcCtD
Methazolamide—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000871	0.00454	CcSEcCtD
Methazolamide—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000871	0.00454	CcSEcCtD
Methazolamide—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000856	0.00446	CcSEcCtD
Methazolamide—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.000855	0.00446	CcSEcCtD
Methazolamide—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000854	0.00445	CcSEcCtD
Methazolamide—Malaise—Prednisone—ankylosing spondylitis	0.000849	0.00443	CcSEcCtD
Methazolamide—Vertigo—Prednisone—ankylosing spondylitis	0.000846	0.00441	CcSEcCtD
Methazolamide—Tinnitus—Methotrexate—ankylosing spondylitis	0.000843	0.00439	CcSEcCtD
Methazolamide—Anorexia—Dexamethasone—ankylosing spondylitis	0.000841	0.00438	CcSEcCtD
Methazolamide—Anorexia—Betamethasone—ankylosing spondylitis	0.000841	0.00438	CcSEcCtD
Methazolamide—Urticaria—Prednisolone—ankylosing spondylitis	0.00084	0.00438	CcSEcCtD
Methazolamide—Fatigue—Triamcinolone—ankylosing spondylitis	0.000838	0.00437	CcSEcCtD
Methazolamide—Fatigue—Methylprednisolone—ankylosing spondylitis	0.000836	0.00436	CcSEcCtD
Methazolamide—Convulsion—Prednisone—ankylosing spondylitis	0.000816	0.00425	CcSEcCtD
Methazolamide—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000801	0.00418	CcSEcCtD
Methazolamide—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000799	0.00417	CcSEcCtD
Methazolamide—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000792	0.00413	CcSEcCtD
Methazolamide—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000792	0.00413	CcSEcCtD
Methazolamide—Discomfort—Prednisone—ankylosing spondylitis	0.000792	0.00413	CcSEcCtD
Methazolamide—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000777	0.00405	CcSEcCtD
Methazolamide—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000777	0.00405	CcSEcCtD
Methazolamide—Urticaria—Triamcinolone—ankylosing spondylitis	0.000772	0.00403	CcSEcCtD
Methazolamide—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000771	0.00402	CcSEcCtD
Methazolamide—Dysgeusia—Methotrexate—ankylosing spondylitis	0.00077	0.00402	CcSEcCtD
Methazolamide—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000769	0.00401	CcSEcCtD
Methazolamide—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000768	0.00401	CcSEcCtD
Methazolamide—Decreased appetite—Betamethasone—ankylosing spondylitis	0.000767	0.004	CcSEcCtD
Methazolamide—Decreased appetite—Dexamethasone—ankylosing spondylitis	0.000767	0.004	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000762	0.00397	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000762	0.00397	CcSEcCtD
Methazolamide—Fatigue—Betamethasone—ankylosing spondylitis	0.000761	0.00397	CcSEcCtD
Methazolamide—Fatigue—Dexamethasone—ankylosing spondylitis	0.000761	0.00397	CcSEcCtD
Methazolamide—Anorexia—Prednisone—ankylosing spondylitis	0.000732	0.00382	CcSEcCtD
Methazolamide—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.00073	0.00381	CcSEcCtD
Methazolamide—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000727	0.00379	CcSEcCtD
Methazolamide—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000727	0.00379	CcSEcCtD
Methazolamide—Malaise—Methotrexate—ankylosing spondylitis	0.00071	0.0037	CcSEcCtD
Methazolamide—Vertigo—Methotrexate—ankylosing spondylitis	0.000707	0.00369	CcSEcCtD
Methazolamide—Leukopenia—Methotrexate—ankylosing spondylitis	0.000704	0.00367	CcSEcCtD
Methazolamide—Urticaria—Betamethasone—ankylosing spondylitis	0.000701	0.00365	CcSEcCtD
Methazolamide—Urticaria—Dexamethasone—ankylosing spondylitis	0.000701	0.00365	CcSEcCtD
Methazolamide—Asthenia—Triamcinolone—ankylosing spondylitis	0.000698	0.00364	CcSEcCtD
Methazolamide—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000697	0.00364	CcSEcCtD
Methazolamide—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000697	0.00364	CcSEcCtD
Methazolamide—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000696	0.00363	CcSEcCtD
Methazolamide—Paraesthesia—Prednisone—ankylosing spondylitis	0.00069	0.0036	CcSEcCtD
Methazolamide—Convulsion—Methotrexate—ankylosing spondylitis	0.000682	0.00355	CcSEcCtD
Methazolamide—Dyspepsia—Prednisone—ankylosing spondylitis	0.000676	0.00353	CcSEcCtD
Methazolamide—Decreased appetite—Prednisone—ankylosing spondylitis	0.000668	0.00348	CcSEcCtD
Methazolamide—Rash—Prednisolone—ankylosing spondylitis	0.000667	0.00348	CcSEcCtD
Methazolamide—Dermatitis—Prednisolone—ankylosing spondylitis	0.000666	0.00347	CcSEcCtD
Methazolamide—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000664	0.00346	CcSEcCtD
Methazolamide—Fatigue—Prednisone—ankylosing spondylitis	0.000662	0.00345	CcSEcCtD
Methazolamide—Headache—Prednisolone—ankylosing spondylitis	0.000662	0.00345	CcSEcCtD
Methazolamide—Discomfort—Methotrexate—ankylosing spondylitis	0.000662	0.00345	CcSEcCtD
Methazolamide—Confusional state—Methotrexate—ankylosing spondylitis	0.000647	0.00338	CcSEcCtD
Methazolamide—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000642	0.00335	CcSEcCtD
Methazolamide—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000633	0.0033	CcSEcCtD
Methazolamide—Asthenia—Dexamethasone—ankylosing spondylitis	0.000633	0.0033	CcSEcCtD
Methazolamide—Asthenia—Betamethasone—ankylosing spondylitis	0.000633	0.0033	CcSEcCtD
Methazolamide—Nausea—Prednisolone—ankylosing spondylitis	0.000628	0.00327	CcSEcCtD
Methazolamide—Vomiting—Triamcinolone—ankylosing spondylitis	0.000618	0.00322	CcSEcCtD
Methazolamide—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000617	0.00322	CcSEcCtD
Methazolamide—Rash—Triamcinolone—ankylosing spondylitis	0.000613	0.0032	CcSEcCtD
Methazolamide—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000613	0.00319	CcSEcCtD
Methazolamide—Anorexia—Methotrexate—ankylosing spondylitis	0.000612	0.00319	CcSEcCtD
Methazolamide—Rash—Methylprednisolone—ankylosing spondylitis	0.000612	0.00319	CcSEcCtD
Methazolamide—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000611	0.00319	CcSEcCtD
Methazolamide—Urticaria—Prednisone—ankylosing spondylitis	0.00061	0.00318	CcSEcCtD
Methazolamide—Headache—Triamcinolone—ankylosing spondylitis	0.000609	0.00318	CcSEcCtD
Methazolamide—Headache—Methylprednisolone—ankylosing spondylitis	0.000608	0.00317	CcSEcCtD
Methazolamide—Body temperature increased—Prednisone—ankylosing spondylitis	0.000607	0.00317	CcSEcCtD
Methazolamide—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000604	0.00315	CcSEcCtD
Methazolamide—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000604	0.00315	CcSEcCtD
Methazolamide—Nausea—Triamcinolone—ankylosing spondylitis	0.000578	0.00301	CcSEcCtD
Methazolamide—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000577	0.00301	CcSEcCtD
Methazolamide—Nausea—Methylprednisolone—ankylosing spondylitis	0.000576	0.003	CcSEcCtD
Methazolamide—Somnolence—Methotrexate—ankylosing spondylitis	0.000571	0.00298	CcSEcCtD
Methazolamide—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000565	0.00295	CcSEcCtD
Methazolamide—Vomiting—Dexamethasone—ankylosing spondylitis	0.000561	0.00292	CcSEcCtD
Methazolamide—Vomiting—Betamethasone—ankylosing spondylitis	0.000561	0.00292	CcSEcCtD
Methazolamide—Decreased appetite—Methotrexate—ankylosing spondylitis	0.000558	0.00291	CcSEcCtD
Methazolamide—Rash—Betamethasone—ankylosing spondylitis	0.000556	0.0029	CcSEcCtD
Methazolamide—Rash—Dexamethasone—ankylosing spondylitis	0.000556	0.0029	CcSEcCtD
Methazolamide—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000556	0.0029	CcSEcCtD
Methazolamide—Dermatitis—Betamethasone—ankylosing spondylitis	0.000556	0.0029	CcSEcCtD
Methazolamide—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000554	0.00289	CcSEcCtD
Methazolamide—Fatigue—Methotrexate—ankylosing spondylitis	0.000554	0.00289	CcSEcCtD
Methazolamide—Headache—Betamethasone—ankylosing spondylitis	0.000553	0.00288	CcSEcCtD
Methazolamide—Headache—Dexamethasone—ankylosing spondylitis	0.000553	0.00288	CcSEcCtD
Methazolamide—Asthenia—Prednisone—ankylosing spondylitis	0.000551	0.00287	CcSEcCtD
Methazolamide—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000529	0.00276	CcSEcCtD
Methazolamide—Diarrhoea—Prednisone—ankylosing spondylitis	0.000526	0.00274	CcSEcCtD
Methazolamide—Nausea—Betamethasone—ankylosing spondylitis	0.000524	0.00273	CcSEcCtD
Methazolamide—Nausea—Dexamethasone—ankylosing spondylitis	0.000524	0.00273	CcSEcCtD
Methazolamide—Urticaria—Methotrexate—ankylosing spondylitis	0.00051	0.00266	CcSEcCtD
Methazolamide—Body temperature increased—Methotrexate—ankylosing spondylitis	0.000508	0.00265	CcSEcCtD
Methazolamide—Vomiting—Prednisone—ankylosing spondylitis	0.000489	0.00255	CcSEcCtD
Methazolamide—Rash—Prednisone—ankylosing spondylitis	0.000484	0.00253	CcSEcCtD
Methazolamide—Dermatitis—Prednisone—ankylosing spondylitis	0.000484	0.00252	CcSEcCtD
Methazolamide—Headache—Prednisone—ankylosing spondylitis	0.000481	0.00251	CcSEcCtD
Methazolamide—Asthenia—Methotrexate—ankylosing spondylitis	0.000461	0.0024	CcSEcCtD
Methazolamide—Nausea—Prednisone—ankylosing spondylitis	0.000456	0.00238	CcSEcCtD
Methazolamide—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000439	0.00229	CcSEcCtD
Methazolamide—Vomiting—Methotrexate—ankylosing spondylitis	0.000408	0.00213	CcSEcCtD
Methazolamide—Rash—Methotrexate—ankylosing spondylitis	0.000405	0.00211	CcSEcCtD
Methazolamide—Dermatitis—Methotrexate—ankylosing spondylitis	0.000404	0.00211	CcSEcCtD
Methazolamide—Headache—Methotrexate—ankylosing spondylitis	0.000402	0.0021	CcSEcCtD
Methazolamide—Nausea—Methotrexate—ankylosing spondylitis	0.000381	0.00199	CcSEcCtD
